ATHA: Athira Pharma, Inc. Stock

by  •  • Comments Off on ATHA: Athira Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10.43
Enterprise Value ($M) -38.01
Book Value ($M) 44.84
Book Value / Share 1.15
Price / Book 0.23
NCAV ($M) 40.90
NCAV / Share 1.05
Price / NCAV 0.26

Profitability (mra)
Return on Invested Capital (ROIC) -2.10
Return on Assets (ROA) -0.73
Return on Equity (ROE) -0.91

Liquidity (mrq)
Quick Ratio 4.18
Current Ratio 4.18

Balance Sheet (mrq) ($M)
Current Assets 54.84
Assets 58.78
Liabilities 13.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -96.78
Net Income -96.94

Cash Flow Statement (mra) ($M)
Cash From Operations -97.17
Cash from Investing 54.83
Cash from Financing 0.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-16 13G Oliveira Steven Michael 5.11
02-14 13G/A BML Investment Partners, L.P. 6.50 0.00
11-14 13G/A Baker Bros. Advisors Lp 0.00 -100.00
10-31 13D/A Perceptive Advisors Llc 14.20 0.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 24,277 91,647 26.49
2025-05-07 10,506 251,310 4.18
2025-05-06 9,449 129,814 7.28
2025-05-05 11,699 92,140 12.70

(click for more detail)

Similar Companies
ARTL – Artelo Biosciences, Inc. ASNS – Actelis Networks, Inc.
ASRT – Assertio Holdings, Inc. ATNF – 180 Life Sciences Corp.
ATOS – Atossa Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io